Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
TARS
— Tarsus Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q3 2025 Earnings Call Summary
NOV 4, 2025
REVENUE
$118.7M
+15.6%
NET MARGIN
-10.6%
+9.2 PTS
EPS
-$0.30
+37.5%
FREE CASH FLOW
$16.3M
+153.8%
No summary has been written for this call yet.
← NEWER CALL
CALL 4 OF 4
OLDER CALL →